Global Small Molecule Anti-tumor Targted Drug Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Small Molecule Anti-tumor Targted Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Anti-tumor Targted Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Anti-tumor Targted Drug market in any manner.
Global Small Molecule Anti-tumor Targted Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Market Segmentation (by Type)
EGFR
ALK
Bcr-Abl
Others
Market Segmentation (by Application)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Anti-tumor Targted Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Small Molecule Anti-tumor Targted Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Small Molecule Anti-tumor Targted Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Small Molecule Anti-tumor Targted Drug market in any manner.
Global Small Molecule Anti-tumor Targted Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Market Segmentation (by Type)
EGFR
ALK
Bcr-Abl
Others
Market Segmentation (by Application)
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Small Molecule Anti-tumor Targted Drug Market
- Overview of the regional outlook of the Small Molecule Anti-tumor Targted Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Small Molecule Anti-tumor Targted Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Small Molecule Anti-tumor Targted Drug
1.2 Key Market Segments
1.2.1 Small Molecule Anti-tumor Targted Drug Segment by Type
1.2.2 Small Molecule Anti-tumor Targted Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Small Molecule Anti-tumor Targted Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Small Molecule Anti-tumor Targted Drug Sales by Manufacturers (2019-2024)
3.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Small Molecule Anti-tumor Targted Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Small Molecule Anti-tumor Targted Drug Sales Sites, Area Served, Product Type
3.6 Small Molecule Anti-tumor Targted Drug Market Competitive Situation and Trends
3.6.1 Small Molecule Anti-tumor Targted Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Small Molecule Anti-tumor Targted Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Anti-tumor Targted Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2019-2024)
6.3 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2019-2024)
6.4 Global Small Molecule Anti-tumor Targted Drug Price by Type (2019-2024)
7 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Anti-tumor Targted Drug Market Sales by Application (2019-2024)
7.3 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
8 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY REGION
8.1 Global Small Molecule Anti-tumor Targted Drug Sales by Region
8.1.1 Global Small Molecule Anti-tumor Targted Drug Sales by Region
8.1.2 Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Small Molecule Anti-tumor Targted Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Small Molecule Anti-tumor Targted Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Anti-tumor Targted Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Small Molecule Anti-tumor Targted Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Astrazeneca
9.1.1 Astrazeneca Small Molecule Anti-tumor Targted Drug Basic Information
9.1.2 Astrazeneca Small Molecule Anti-tumor Targted Drug Product Overview
9.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Product Market Performance
9.1.4 Astrazeneca Business Overview
9.1.5 Astrazeneca Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.1.6 Astrazeneca Recent Developments
9.2 Novartis
9.2.1 Novartis Small Molecule Anti-tumor Targted Drug Basic Information
9.2.2 Novartis Small Molecule Anti-tumor Targted Drug Product Overview
9.2.3 Novartis Small Molecule Anti-tumor Targted Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Millennium Pharmaceuticals
9.3.1 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Basic Information
9.3.2 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Overview
9.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Market Performance
9.3.4 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.3.5 Millennium Pharmaceuticals Business Overview
9.3.6 Millennium Pharmaceuticals Recent Developments
9.4 Bayer
9.4.1 Bayer Small Molecule Anti-tumor Targted Drug Basic Information
9.4.2 Bayer Small Molecule Anti-tumor Targted Drug Product Overview
9.4.3 Bayer Small Molecule Anti-tumor Targted Drug Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Recent Developments
9.5 Exelixis
9.5.1 Exelixis Small Molecule Anti-tumor Targted Drug Basic Information
9.5.2 Exelixis Small Molecule Anti-tumor Targted Drug Product Overview
9.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Product Market Performance
9.5.4 Exelixis Business Overview
9.5.5 Exelixis Recent Developments
9.6 Abbvie
9.6.1 Abbvie Small Molecule Anti-tumor Targted Drug Basic Information
9.6.2 Abbvie Small Molecule Anti-tumor Targted Drug Product Overview
9.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Product Market Performance
9.6.4 Abbvie Business Overview
9.6.5 Abbvie Recent Developments
9.7 Boehringer-Ingelheim
9.7.1 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Basic Information
9.7.2 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Overview
9.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Market Performance
9.7.4 Boehringer-Ingelheim Business Overview
9.7.5 Boehringer-Ingelheim Recent Developments
9.8 Eisai
9.8.1 Eisai Small Molecule Anti-tumor Targted Drug Basic Information
9.8.2 Eisai Small Molecule Anti-tumor Targted Drug Product Overview
9.8.3 Eisai Small Molecule Anti-tumor Targted Drug Product Market Performance
9.8.4 Eisai Business Overview
9.8.5 Eisai Recent Developments
9.9 Pfizer
9.9.1 Pfizer Small Molecule Anti-tumor Targted Drug Basic Information
9.9.2 Pfizer Small Molecule Anti-tumor Targted Drug Product Overview
9.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Basic Information
9.10.2 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Overview
9.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Market Performance
9.10.4 Bristol-Myers Squibb Business Overview
9.10.5 Bristol-Myers Squibb Recent Developments
9.11 Roche
9.11.1 Roche Small Molecule Anti-tumor Targted Drug Basic Information
9.11.2 Roche Small Molecule Anti-tumor Targted Drug Product Overview
9.11.3 Roche Small Molecule Anti-tumor Targted Drug Product Market Performance
9.11.4 Roche Business Overview
9.11.5 Roche Recent Developments
9.12 Bettapharma
9.12.1 Bettapharma Small Molecule Anti-tumor Targted Drug Basic Information
9.12.2 Bettapharma Small Molecule Anti-tumor Targted Drug Product Overview
9.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Product Market Performance
9.12.4 Bettapharma Business Overview
9.12.5 Bettapharma Recent Developments
10 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET FORECAST BY REGION
10.1 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast
10.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country
10.2.3 Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region
10.2.4 South America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Small Molecule Anti-tumor Targted Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Small Molecule Anti-tumor Targted Drug by Type (2025-2030)
11.1.2 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Small Molecule Anti-tumor Targted Drug by Type (2025-2030)
11.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Application (2025-2030)
11.2.1 Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Small Molecule Anti-tumor Targted Drug
1.2 Key Market Segments
1.2.1 Small Molecule Anti-tumor Targted Drug Segment by Type
1.2.2 Small Molecule Anti-tumor Targted Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Small Molecule Anti-tumor Targted Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Small Molecule Anti-tumor Targted Drug Sales by Manufacturers (2019-2024)
3.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Small Molecule Anti-tumor Targted Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Small Molecule Anti-tumor Targted Drug Sales Sites, Area Served, Product Type
3.6 Small Molecule Anti-tumor Targted Drug Market Competitive Situation and Trends
3.6.1 Small Molecule Anti-tumor Targted Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Small Molecule Anti-tumor Targted Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG INDUSTRY CHAIN ANALYSIS
4.1 Small Molecule Anti-tumor Targted Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2019-2024)
6.3 Global Small Molecule Anti-tumor Targted Drug Market Size Market Share by Type (2019-2024)
6.4 Global Small Molecule Anti-tumor Targted Drug Price by Type (2019-2024)
7 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Small Molecule Anti-tumor Targted Drug Market Sales by Application (2019-2024)
7.3 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
8 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET SEGMENTATION BY REGION
8.1 Global Small Molecule Anti-tumor Targted Drug Sales by Region
8.1.1 Global Small Molecule Anti-tumor Targted Drug Sales by Region
8.1.2 Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Small Molecule Anti-tumor Targted Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Small Molecule Anti-tumor Targted Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Small Molecule Anti-tumor Targted Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Small Molecule Anti-tumor Targted Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Astrazeneca
9.1.1 Astrazeneca Small Molecule Anti-tumor Targted Drug Basic Information
9.1.2 Astrazeneca Small Molecule Anti-tumor Targted Drug Product Overview
9.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Product Market Performance
9.1.4 Astrazeneca Business Overview
9.1.5 Astrazeneca Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.1.6 Astrazeneca Recent Developments
9.2 Novartis
9.2.1 Novartis Small Molecule Anti-tumor Targted Drug Basic Information
9.2.2 Novartis Small Molecule Anti-tumor Targted Drug Product Overview
9.2.3 Novartis Small Molecule Anti-tumor Targted Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Millennium Pharmaceuticals
9.3.1 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Basic Information
9.3.2 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Overview
9.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Market Performance
9.3.4 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug SWOT Analysis
9.3.5 Millennium Pharmaceuticals Business Overview
9.3.6 Millennium Pharmaceuticals Recent Developments
9.4 Bayer
9.4.1 Bayer Small Molecule Anti-tumor Targted Drug Basic Information
9.4.2 Bayer Small Molecule Anti-tumor Targted Drug Product Overview
9.4.3 Bayer Small Molecule Anti-tumor Targted Drug Product Market Performance
9.4.4 Bayer Business Overview
9.4.5 Bayer Recent Developments
9.5 Exelixis
9.5.1 Exelixis Small Molecule Anti-tumor Targted Drug Basic Information
9.5.2 Exelixis Small Molecule Anti-tumor Targted Drug Product Overview
9.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Product Market Performance
9.5.4 Exelixis Business Overview
9.5.5 Exelixis Recent Developments
9.6 Abbvie
9.6.1 Abbvie Small Molecule Anti-tumor Targted Drug Basic Information
9.6.2 Abbvie Small Molecule Anti-tumor Targted Drug Product Overview
9.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Product Market Performance
9.6.4 Abbvie Business Overview
9.6.5 Abbvie Recent Developments
9.7 Boehringer-Ingelheim
9.7.1 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Basic Information
9.7.2 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Overview
9.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Market Performance
9.7.4 Boehringer-Ingelheim Business Overview
9.7.5 Boehringer-Ingelheim Recent Developments
9.8 Eisai
9.8.1 Eisai Small Molecule Anti-tumor Targted Drug Basic Information
9.8.2 Eisai Small Molecule Anti-tumor Targted Drug Product Overview
9.8.3 Eisai Small Molecule Anti-tumor Targted Drug Product Market Performance
9.8.4 Eisai Business Overview
9.8.5 Eisai Recent Developments
9.9 Pfizer
9.9.1 Pfizer Small Molecule Anti-tumor Targted Drug Basic Information
9.9.2 Pfizer Small Molecule Anti-tumor Targted Drug Product Overview
9.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Product Market Performance
9.9.4 Pfizer Business Overview
9.9.5 Pfizer Recent Developments
9.10 Bristol-Myers Squibb
9.10.1 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Basic Information
9.10.2 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Overview
9.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Market Performance
9.10.4 Bristol-Myers Squibb Business Overview
9.10.5 Bristol-Myers Squibb Recent Developments
9.11 Roche
9.11.1 Roche Small Molecule Anti-tumor Targted Drug Basic Information
9.11.2 Roche Small Molecule Anti-tumor Targted Drug Product Overview
9.11.3 Roche Small Molecule Anti-tumor Targted Drug Product Market Performance
9.11.4 Roche Business Overview
9.11.5 Roche Recent Developments
9.12 Bettapharma
9.12.1 Bettapharma Small Molecule Anti-tumor Targted Drug Basic Information
9.12.2 Bettapharma Small Molecule Anti-tumor Targted Drug Product Overview
9.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Product Market Performance
9.12.4 Bettapharma Business Overview
9.12.5 Bettapharma Recent Developments
10 SMALL MOLECULE ANTI-TUMOR TARGTED DRUG MARKET FORECAST BY REGION
10.1 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast
10.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country
10.2.3 Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region
10.2.4 South America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Small Molecule Anti-tumor Targted Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Small Molecule Anti-tumor Targted Drug by Type (2025-2030)
11.1.2 Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Small Molecule Anti-tumor Targted Drug by Type (2025-2030)
11.2 Global Small Molecule Anti-tumor Targted Drug Market Forecast by Application (2025-2030)
11.2.1 Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Anti-tumor Targted Drug Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Small Molecule Anti-tumor Targted Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2022)
Table 10. Global Market Small Molecule Anti-tumor Targted Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Small Molecule Anti-tumor Targted Drug Sales Sites and Area Served
Table 12. Manufacturers Small Molecule Anti-tumor Targted Drug Product Type
Table 13. Global Small Molecule Anti-tumor Targted Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Small Molecule Anti-tumor Targted Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Anti-tumor Targted Drug Market Challenges
Table 22. Global Small Molecule Anti-tumor Targted Drug Sales by Type (Kilotons)
Table 23. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (M USD)
Table 24. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2019-2024)
Table 26. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Type (2019-2024)
Table 28. Global Small Molecule Anti-tumor Targted Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Application
Table 30. Global Small Molecule Anti-tumor Targted Drug Market Size by Application
Table 31. Global Small Molecule Anti-tumor Targted Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2019-2024)
Table 33. Global Small Molecule Anti-tumor Targted Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2024)
Table 35. Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region (2019-2024)
Table 38. North America Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Astrazeneca Small Molecule Anti-tumor Targted Drug Basic Information
Table 44. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Overview
Table 45. Astrazeneca Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Astrazeneca Business Overview
Table 47. Astrazeneca Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 48. Astrazeneca Recent Developments
Table 49. Novartis Small Molecule Anti-tumor Targted Drug Basic Information
Table 50. Novartis Small Molecule Anti-tumor Targted Drug Product Overview
Table 51. Novartis Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Basic Information
Table 56. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Overview
Table 57. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 59. Millennium Pharmaceuticals Business Overview
Table 60. Millennium Pharmaceuticals Recent Developments
Table 61. Bayer Small Molecule Anti-tumor Targted Drug Basic Information
Table 62. Bayer Small Molecule Anti-tumor Targted Drug Product Overview
Table 63. Bayer Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer Business Overview
Table 65. Bayer Recent Developments
Table 66. Exelixis Small Molecule Anti-tumor Targted Drug Basic Information
Table 67. Exelixis Small Molecule Anti-tumor Targted Drug Product Overview
Table 68. Exelixis Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Exelixis Business Overview
Table 70. Exelixis Recent Developments
Table 71. Abbvie Small Molecule Anti-tumor Targted Drug Basic Information
Table 72. Abbvie Small Molecule Anti-tumor Targted Drug Product Overview
Table 73. Abbvie Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Abbvie Business Overview
Table 75. Abbvie Recent Developments
Table 76. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Basic Information
Table 77. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Overview
Table 78. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Boehringer-Ingelheim Business Overview
Table 80. Boehringer-Ingelheim Recent Developments
Table 81. Eisai Small Molecule Anti-tumor Targted Drug Basic Information
Table 82. Eisai Small Molecule Anti-tumor Targted Drug Product Overview
Table 83. Eisai Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Eisai Business Overview
Table 85. Eisai Recent Developments
Table 86. Pfizer Small Molecule Anti-tumor Targted Drug Basic Information
Table 87. Pfizer Small Molecule Anti-tumor Targted Drug Product Overview
Table 88. Pfizer Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Pfizer Business Overview
Table 90. Pfizer Recent Developments
Table 91. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Basic Information
Table 92. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Overview
Table 93. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Recent Developments
Table 96. Roche Small Molecule Anti-tumor Targted Drug Basic Information
Table 97. Roche Small Molecule Anti-tumor Targted Drug Product Overview
Table 98. Roche Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Roche Business Overview
Table 100. Roche Recent Developments
Table 101. Bettapharma Small Molecule Anti-tumor Targted Drug Basic Information
Table 102. Bettapharma Small Molecule Anti-tumor Targted Drug Product Overview
Table 103. Bettapharma Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bettapharma Business Overview
Table 105. Bettapharma Recent Developments
Table 106. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Small Molecule Anti-tumor Targted Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Small Molecule Anti-tumor Targted Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Small Molecule Anti-tumor Targted Drug Market Size Comparison by Region (M USD)
Table 5. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Small Molecule Anti-tumor Targted Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2022)
Table 10. Global Market Small Molecule Anti-tumor Targted Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Small Molecule Anti-tumor Targted Drug Sales Sites and Area Served
Table 12. Manufacturers Small Molecule Anti-tumor Targted Drug Product Type
Table 13. Global Small Molecule Anti-tumor Targted Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Small Molecule Anti-tumor Targted Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Small Molecule Anti-tumor Targted Drug Market Challenges
Table 22. Global Small Molecule Anti-tumor Targted Drug Sales by Type (Kilotons)
Table 23. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (M USD)
Table 24. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Type (2019-2024)
Table 26. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Type (2019-2024)
Table 28. Global Small Molecule Anti-tumor Targted Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) by Application
Table 30. Global Small Molecule Anti-tumor Targted Drug Market Size by Application
Table 31. Global Small Molecule Anti-tumor Targted Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2019-2024)
Table 33. Global Small Molecule Anti-tumor Targted Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2024)
Table 35. Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region (2019-2024)
Table 38. North America Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Small Molecule Anti-tumor Targted Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Astrazeneca Small Molecule Anti-tumor Targted Drug Basic Information
Table 44. Astrazeneca Small Molecule Anti-tumor Targted Drug Product Overview
Table 45. Astrazeneca Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Astrazeneca Business Overview
Table 47. Astrazeneca Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 48. Astrazeneca Recent Developments
Table 49. Novartis Small Molecule Anti-tumor Targted Drug Basic Information
Table 50. Novartis Small Molecule Anti-tumor Targted Drug Product Overview
Table 51. Novartis Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Basic Information
Table 56. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product Overview
Table 57. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug SWOT Analysis
Table 59. Millennium Pharmaceuticals Business Overview
Table 60. Millennium Pharmaceuticals Recent Developments
Table 61. Bayer Small Molecule Anti-tumor Targted Drug Basic Information
Table 62. Bayer Small Molecule Anti-tumor Targted Drug Product Overview
Table 63. Bayer Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bayer Business Overview
Table 65. Bayer Recent Developments
Table 66. Exelixis Small Molecule Anti-tumor Targted Drug Basic Information
Table 67. Exelixis Small Molecule Anti-tumor Targted Drug Product Overview
Table 68. Exelixis Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Exelixis Business Overview
Table 70. Exelixis Recent Developments
Table 71. Abbvie Small Molecule Anti-tumor Targted Drug Basic Information
Table 72. Abbvie Small Molecule Anti-tumor Targted Drug Product Overview
Table 73. Abbvie Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Abbvie Business Overview
Table 75. Abbvie Recent Developments
Table 76. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Basic Information
Table 77. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product Overview
Table 78. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Boehringer-Ingelheim Business Overview
Table 80. Boehringer-Ingelheim Recent Developments
Table 81. Eisai Small Molecule Anti-tumor Targted Drug Basic Information
Table 82. Eisai Small Molecule Anti-tumor Targted Drug Product Overview
Table 83. Eisai Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Eisai Business Overview
Table 85. Eisai Recent Developments
Table 86. Pfizer Small Molecule Anti-tumor Targted Drug Basic Information
Table 87. Pfizer Small Molecule Anti-tumor Targted Drug Product Overview
Table 88. Pfizer Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Pfizer Business Overview
Table 90. Pfizer Recent Developments
Table 91. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Basic Information
Table 92. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product Overview
Table 93. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Recent Developments
Table 96. Roche Small Molecule Anti-tumor Targted Drug Basic Information
Table 97. Roche Small Molecule Anti-tumor Targted Drug Product Overview
Table 98. Roche Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Roche Business Overview
Table 100. Roche Recent Developments
Table 101. Bettapharma Small Molecule Anti-tumor Targted Drug Basic Information
Table 102. Bettapharma Small Molecule Anti-tumor Targted Drug Product Overview
Table 103. Bettapharma Small Molecule Anti-tumor Targted Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bettapharma Business Overview
Table 105. Bettapharma Recent Developments
Table 106. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Small Molecule Anti-tumor Targted Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Small Molecule Anti-tumor Targted Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Small Molecule Anti-tumor Targted Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Small Molecule Anti-tumor Targted Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Small Molecule Anti-tumor Targted Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Small Molecule Anti-tumor Targted Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD), 2019-2030
Figure 5. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) (2019-2030)
Figure 6. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Anti-tumor Targted Drug Market Size by Country (M USD)
Figure 11. Small Molecule Anti-tumor Targted Drug Sales Share by Manufacturers in 2023
Figure 12. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Manufacturers in 2023
Figure 13. Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Small Molecule Anti-tumor Targted Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Type
Figure 18. Sales Market Share of Small Molecule Anti-tumor Targted Drug by Type (2019-2024)
Figure 19. Sales Market Share of Small Molecule Anti-tumor Targted Drug by Type in 2023
Figure 20. Market Size Share of Small Molecule Anti-tumor Targted Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Small Molecule Anti-tumor Targted Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Small Molecule Anti-tumor Targted Drug Market Share by Application
Figure 24. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application in 2023
Figure 26. Global Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2024)
Figure 27. Global Small Molecule Anti-tumor Targted Drug Market Share by Application in 2023
Figure 28. Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 32. U.S. Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Small Molecule Anti-tumor Targted Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Small Molecule Anti-tumor Targted Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 37. Germany Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales Market Share by Region in 2023
Figure 44. China Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 51. Brazil Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Small Molecule Anti-tumor Targted Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Small Molecule Anti-tumor Targted Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD), 2019-2030
Figure 5. Global Small Molecule Anti-tumor Targted Drug Market Size (M USD) (2019-2030)
Figure 6. Global Small Molecule Anti-tumor Targted Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Small Molecule Anti-tumor Targted Drug Market Size by Country (M USD)
Figure 11. Small Molecule Anti-tumor Targted Drug Sales Share by Manufacturers in 2023
Figure 12. Global Small Molecule Anti-tumor Targted Drug Revenue Share by Manufacturers in 2023
Figure 13. Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Small Molecule Anti-tumor Targted Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Type
Figure 18. Sales Market Share of Small Molecule Anti-tumor Targted Drug by Type (2019-2024)
Figure 19. Sales Market Share of Small Molecule Anti-tumor Targted Drug by Type in 2023
Figure 20. Market Size Share of Small Molecule Anti-tumor Targted Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Small Molecule Anti-tumor Targted Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Small Molecule Anti-tumor Targted Drug Market Share by Application
Figure 24. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Application in 2023
Figure 26. Global Small Molecule Anti-tumor Targted Drug Market Share by Application (2019-2024)
Figure 27. Global Small Molecule Anti-tumor Targted Drug Market Share by Application in 2023
Figure 28. Global Small Molecule Anti-tumor Targted Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Small Molecule Anti-tumor Targted Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 32. U.S. Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Small Molecule Anti-tumor Targted Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Small Molecule Anti-tumor Targted Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 37. Germany Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Small Molecule Anti-tumor Targted Drug Sales Market Share by Region in 2023
Figure 44. China Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Small Molecule Anti-tumor Targted Drug Sales Market Share by Country in 2023
Figure 51. Brazil Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Small Molecule Anti-tumor Targted Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Small Molecule Anti-tumor Targted Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Small Molecule Anti-tumor Targted Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Small Molecule Anti-tumor Targted Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Small Molecule Anti-tumor Targted Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Small Molecule Anti-tumor Targted Drug Market Share Forecast by Application (2025-2030)
